Aluminium in Allergies and Allergen immunotherapy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bousfield, 1947, Clinical trials of diphtheria toxoid aluminium-phosphate-precipitated; to determine optional aluminium-phosphate content, Lancet, 1, 286, 10.1016/S0140-6736(47)90095-0
Mc Comb, 1950, Immune responses and reactions to diphtheria and tetanus toxoids, with pertussis vaccine, aluminum phosphate precipitated, N Engl J Med, 243, 442, 10.1056/NEJM195009212431204
Baylor, 2002, Aluminum salts in vaccines–US perspective, Vaccine, 20, S18, 10.1016/S0264-410X(02)00166-4
Lindblad, 2004, Aluminium compounds for use in vaccines, Immunol Cell Biol, 82, 497, 10.1111/j.0818-9641.2004.01286.x
Hussels F. [Eight to twelve month follow-up of the results of rapid treatment of syphilis with PAM, procaine penicillin G in oil with aluminum monostearate]. Therapie der Gegenwart. 1950;89:332–6.
Bohls, 1946, Oral and parenteral use of aluminum penicillin mixtures in the treatment of gonorrhea, J Vener Dis Inf, 27, 69
Hirsh, 1950, The treatment of various infections with single doses of 300,000 units of procaine penicillin in oil plus aluminum monostearate, Am Pract Dig Treat, 1, 923
McIntosh, 1940, The Use of Colloidal Aluminium Hydroxide in the Treatment of Peptic Ulcer, Can Med Assoc J, 42, 140
Rossien, 1951, An evaluation of the antacid activity of a “special” aluminum hydroxide mixture, Rev Gastroenterol, 18, 535
Friedman, 1946, Aluminum hydroxide gel for erosions in patients with bowel fistulas, JAMA, 131, 520, 10.1001/jama.1946.02870230026006a
Clark, 1947, The effect of gastric antacids on gastric secretion as observed in the Cope pouch dog; sodium bicarbonate, aluminum hydroxide gel, calcium carbonate, magnesium oxide, and sodium citrate, Gastroenterology, 9, 284
Akdis, 2009, Therapeutic manipulation of immune tolerance in allergic disease, Nat Rev Drug Discov, 8, 645, 10.1038/nrd2653
Soyka, 2012, Regulatory cells in allergen-specific immunotherapy, Immunotherapy, 4, 389, 10.2217/imt.12.10
Holgate, 2008, Treatment strategies for allergy and asthma, Nat Rev Immunol, 8, 218, 10.1038/nri2262
Jarolim, 1990, A long-term follow-up study of hyposensitization with immunoblotting, J Allergy Clin Immunol, 85, 996, 10.1016/0091-6749(90)90043-4
Freeman, 1911, Further observations on the treatment of Hay fever by hypodermic inoculations of pollen vaccine, Lancet, 2, 814, 10.1016/S0140-6736(01)40417-X
Noon, 1911, Prophylactic inoculation against hay fever, Lancet, 1, 1572, 10.1016/S0140-6736(00)78276-6
Zoss, 1937, Alum-ragweed precipitate: preparation and clinical investigation; preliminary, J Allergy, 8, 329, 10.1016/S0021-8707(37)90140-0
Naterman, 1951, Pollen tannate suspended in peanut oil with aluminum monostearate in the treatment of hay fever, J Allergy, 22, 175, 10.1016/0021-8707(51)90058-5
Holzman, 1966, The effect of alum concentration on the repository and adjuvant properties of alum-precipitated antigens, J Allergy, 38, 65, 10.1016/0021-8707(66)90045-1
Levine, 1970, Effect of combinations of inbred strain, antigen, and antigen dose on immune responsiveness and reagin production in the mouse. A potential mouse model for immune aspects of human atopic allergy, Int Arch Allergy Appl Immunol, 39, 156, 10.1159/000230343
Revoltella, 1969, Preferential production of rabbit reaginic antibodies, Int Arch Allergy Appl Immunol, 36, 282, 10.1159/000230749
Revoltella, 1969, Reaginic antibody production in different mouse strains, Immunology, 17, 45
Black, 1977, The adjuvant activity of saponin and aluminium hydroxide for promoting reagins, J Immunol Methods, 15, 193, 10.1016/0022-1759(77)90030-8
Lehrer, 1976, Enhancement of reaginic and hemagglutinating antibody production by an extract of Bordetella pertussis containing histamine sensitizing factor, J Immunol, 116, 178
Pauwels, 1983, The non-specific enhancement of allergy. I. In vivo effects of Bordetella pertussis vaccine on IgE synthesis, Allergy, 38, 239, 10.1111/j.1398-9995.1983.tb01617.x
Marsh, 1972, Induction of IgE-mediated immediate hypersensitivity to group I rye grass pollen allergen and allergoids in non-allergic man, Immunology, 22, 1013
Kepron, 1977, A canine model for reaginic hypersensitivity and allergic bronchoconstriction, J Allergy Clin Immunol, 59, 64, 10.1016/0091-6749(77)90178-6
Black, 1977, Allergy in cattle after foot-and-mouth disease vaccination, Vet Rec, 100, 195, 10.1136/vr.100.10.195
Itaya, 1980, Suppression of IgE antibody formation in mice with nonspecific stimulation, Int Arch Allergy Appl Immunol, 62, 389, 10.1159/000232541
Flarend, 1997, A. In vivo absorption of aluminium-containing vaccine adjuvants using 26Al, Vaccine, 15, 1314, 10.1016/S0264-410X(97)00041-8
Brunner, 2010, The ABC of clinical and experimental adjuvants–a brief overview, Immunol Lett, 128, 29, 10.1016/j.imlet.2009.10.005
Moingeon, 2012, Novel routes for allergen immunotherapy: safety, efficacy and mode of action, Immunotherapy, 4, 201, 10.2217/imt.11.171
Ekramoddoullah, 1977, Suppression of the IgE antibody response in mice to kentucky blue grass pollen allergens, Int Arch Allergy Appl Immunol, 55, 247, 10.1159/000231933
Wachholz, 2003, Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy, J Allergy Clin Immunol, 112, 915, 10.1016/S0091-6749(03)02022-0
Hantusch, 2005, Affinity determinations of purified IgE and IgG antibodies against the major pollen allergens Phl p 5a and Bet v 1a: discrepancy between IgE and IgG binding strength, Immunol Lett, 97, 81, 10.1016/j.imlet.2004.10.002
Hogenesch, 2012, Mechanism of immunopotentiation and safety of aluminum adjuvants, Front Immunol, 3, 406
Marrack, 2009, Towards an understanding of the adjuvant action of aluminium, Nat Rev Immunol, 9, 287, 10.1038/nri2510
McKee, 2009, Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity, J Immunol, 183, 4403, 10.4049/jimmunol.0900164
Kuroda, 2013, Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects, Int Rev Immunol, 32, 209, 10.3109/08830185.2013.773326
Pollock, 2003, Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12, Immunology, 108, 137, 10.1046/j.1365-2567.2003.01581.x
Exley C, Siesjo P, Eriksson H. The immunobiology of aluminium adjuvants: how do they really work? Trends Immunol. 2010;31:103–9. doi:10.1016/J.It.2009.12.009
Sun, 2003, Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro, Vaccine, 21, 849, 10.1016/S0264-410X(02)00531-5
Manzano-Szalai K, Thell K, Willensdorfer A, Weghofer M, Pfanzagl B, Singer J, et al. Adeno-associated virus-like particles as new carriers for B-cell vaccines: testing immunogenicity and safety in BALB/c mice. Viral Immunol. 2014. doi:10.1089/vim.2014.0059.
Hebert, 1988, Comparison of alum-precipitated aqueous extracts and modified ragweed tyrosine adsorbate vaccine in the treatment of ragweed hay fever, Ann Allergy, 60, 226
Boye, 1990, Immunotherapy of tree pollen allergy with a modified alginate conjugated birch pollen extract compared to an aluminium adsorbed extract, Allergy, 45, 241, 10.1111/j.1398-9995.1990.tb00491.x
Scholl, 2005, Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy, J Control Release, 104, 1, 10.1016/j.jconrel.2004.12.020
Pali-Scholl I, Szollosi H, Starkl P, Scheicher B, Stremnitzer C, Hofmeister A, et al. Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB/c mice. Eur J Pharm Biopharm. 2013;85:656–64. doi:10.1016/J.Ejpb.2013.03.003
Roth-Walter, 2004, M cell targeting with Aleuria aurantia lectin as a novel approach for oral allergen immunotherapy, J Allergy Clin Immunol, 114, 1362, 10.1016/j.jaci.2004.08.010
Kool, 2012, Alum adjuvant: some of the tricks of the oldest adjuvant, J Med Microbiol, 61, 927, 10.1099/jmm.0.038943-0
Exley, 2014, Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy. Allergy, Asthma, and Clinical Immunology : official journal of the Canadian Society of Allergy and, Clin Immunol, 10, 4
Garcia-Patos, 1995, Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts, Arch Dermatol, 131, 1421, 10.1001/archderm.131.12.1421
Heidary, 2005, Hypersensitivity reactions to vaccine components, Dermatitis : contact, atopic, occupational, drug, 16, 115
Osterballe, 1982, Side effects during immunotherapy with purified grass pollen extracts, Allergy, 37, 553, 10.1111/j.1398-9995.1982.tb02340.x
Netterlid, 2013, Does allergen-specific immunotherapy induce contact allergy to aluminium?, Acta Derm Venereol, 93, 50, 10.2340/00015555-1409
Exley, 2013, Human exposure to aluminium, Environ Sci Processes Impacts, 15, 1807, 10.1039/C3EM00374D
Martyn, 1989, Geographical relation between Alzheimer’s disease and aluminum in drinking water, Lancet, 1, 59, 10.1016/S0140-6736(89)91425-6
World Health Organizaion. Aluminium. Geneva, WHO International Programme on Chemical Safety (Environmental Health Criteria 194). 1997.
European Food Safety Authority, EFSA. Technical report: Dietary exposure to aluminium-containing food additives. http://www.efsa.europa.eu/en/supporting/pub/411e.htm. March 2013.;Parma, Italy:Supporting Publications 2013:EN-411.
Roth, 1987, Localizations of Aluminum in Soybean Bacteroids and Seeds, Appl Environ Microb, 53, 2548, 10.1128/AEM.53.10.2548-2553.1987
Food and Drug Administration, Dept. of Health and Human Services. 21. Food and Drugs. Biologics: General Biological Product Standards. 21CFR61015. 1 April 2014; 7:http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=610.15.
Vaccine-Education-Center. Do vaccines contain aluminum? Reviewed by Offit, PA. http://vec.chop.edu/service/vaccine-education-center/vaccine-safety/vaccine-ingredients/aluminum.html. March 2014.
Willhite, 2014, Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts, Crit Rev Toxicol, 44, 1, 10.3109/10408444.2014.934439
Banasik, 2005, Aluminum-induced micronuclei and apoptosis in human peripheral-blood lymphocytes treated during different phases of the cell cycle, Environ Toxicol, 20, 402, 10.1002/tox.20125
Tomljenovic, 2012, Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations, Lupus, 21, 223, 10.1177/0961203311430221
Schwarz, 2003, Cytokines, neurophysiology, neuropsychology, and psychiatric symptoms, Dialogues Clin Neurosci, 5, 139, 10.31887/DCNS.2003.5.2/mschwarz
Khan, 2013, Slow CCL2-dependent translocation of biopersistent particles from muscle to brain, BMC Med, 11, 99, 10.1186/1741-7015-11-99
De Sole, 2013, Possible relationship between Al/ferritin complex and Alzheimer’s disease, Clin Biochem, 46, 89, 10.1016/j.clinbiochem.2012.10.023
Mold, 2014, Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line, Sci Rep, 4, 6287, 10.1038/srep06287
Brunner, 2009, Aluminium per se and in the anti-acid drug sucralfate promotes sensitization via the oral route, Allergy, 64, 890, 10.1111/j.1398-9995.2008.01933.x
Brunner, 2007, The impact of aluminium in acid-suppressing drugs on the immune response of BALB/c mice, Clin Exp Allergy, 37, 1566, 10.1111/j.1365-2222.2007.02813.x
Rosenblum, 2011, The common immunogenic etiology of chronic fatigue syndrome: from infections to vaccines via adjuvants to the ASIA syndrome, Infect Dis Clin North Am, 25, 851, 10.1016/j.idc.2011.07.012
Perricone, 2013, Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects, J Autoimmun, 47, 1, 10.1016/j.jaut.2013.10.004
Soriano A, Nesher G, Shoenfeld Y. Predicting post-vaccination autoimmunity: Who might be at risk? Pharmacol Res. Epub 2014/10/04. doi:10.1016/j.phrs.2014.08.002.
Commission of the French Parliament. 2/7 Colloque de L’OPECST sur les effets secondaires d’adjuvants vaccinaux. YouTube. 22 May 2014; https://www.youtube.com/watch?v=zmpKMGGiJpg&feature=youtu.be.
Greßler S, Fries R. Aluminium. Toxikologie und gesundheitliche Aspekte bei körpernahen Anwendungen. Publisher: Austrian Ministry of Health, (editor Herzog, U). http://www.bmg.gv.at/cms/home/attachments/3/9/6/CH1146/CMS1402477436830/aluminium_studie_2014.pdf. June 2014.